News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Univec, Inc. (UNVC) Announces Completion of R&D for Nicotine Replacement Patch



7/13/2012 10:12:18 AM

OWINGS MILLS, Md.--(BUSINESS WIRE)--Univec, Inc. (OTC: UNVC) a specialty pharmaceutical company, announces it has completed the R&D for its Nicotine Replacement Patch. Univec anticipates product production by the end of next quarter. Univec's Transdermal Delivery system enhances bioavailability, minimizes pharmaco-kinetic peaks, improves tolerability and dosing, increases patient compliance, and continuous delivery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES